Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 91.99
+1.14 (1.25%)
Aug 19, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 4.99 billion as of August 19, 2026. Its market cap has increased by 2.22% in one year.
Market Cap
4.99B
Enterprise Value
5.13B
Revenue
3.06B
Ranking
n/a
PE Ratio
38.36
Stock Price
91.99
ChartMarket Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 4.99B, a decrease of -32.48%. That is a compound annual growth rate of -12.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 4.99B | 31.37% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 19.88B |
| Windlas Biotech | 19.26B |
| Jagsonpal Pharmaceuticals | 15.22B |
| Sigachi Industries | 10.07B |
| Bafna Pharmaceuticals | 5.85B |
| Amanta Healthcare | 5.64B |
| Nectar Lifesciences | 2.18B |
| Brooks Laboratories | 1.79B |